These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8718547)

  • 1. [Expression of glutathione S-transferase pi and numerical aberration of chromosome 11 in human ovarian cancer as a prognostic indicator].
    Yokoyama Y; Fukushi Y; Kunugi T; Maruyama H; Sato S; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):118-24. PubMed ID: 8718547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
    Li L; Yao D; Chen X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer].
    Huang J; Gu M; Chen C
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):458-61. PubMed ID: 9639737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
    Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
    Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
    Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
    Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic factors for chemotherapy of ovarian cancer.
    Muso H
    Osaka City Med J; 1998 Dec; 44(2):155-71. PubMed ID: 10097596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy.
    Hamada S; Kamada M; Furumoto H; Hirao T; Aono T
    Gynecol Oncol; 1994 Mar; 52(3):313-9. PubMed ID: 8157188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
    Zhang F; Qi L; Chen H
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
    Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
    Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
    Miyatake K; Gemba K; Ueoka H; Nishii K; Kiura K; Tabata M; Shibayama T; Takigawa N; Kawaraya M; Tanimoto M
    Anticancer Res; 2003; 23(3C):2829-36. PubMed ID: 12926120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
    Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
    Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
    Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
    Ali-Osman F; Brunner JM; Kutluk TM; Hess K
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M; Akpolat I; Kandemir B
    Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
    Huang J; Bay BH; Tan PH
    Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.